Latest Series A Funding Rounds
Companies raising their first major institutional growth round, from the product they sell to the investors backing their next stage.
- Rounds
- 881 All time
- Disclosed funding
- $34.2B 795 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| TS Throne ScienceCompany profile A smart toilet sensor that tracks gut health, hydration, and urinary function automatically with every flush. A smart toilet sensor that tracks gut health, hydration, and urinary function automatically with every flush. | $10M | Series A | Healthtech | United States | Investors | |
| H Healia is a healthcare benefits platform built for dual-income families. | $14M | Series A | Fintech | United States | Investors | |
| CB CORE BiomedicineCompany profile Developing the next generation of precision medicines by going beyond genomics. Developing the next generation of precision medicines by going beyond genomics. | $21M | Series A | Biotech | United States | Investors | |
| A AegisAICompany profile AegisAI builds email security that uses language models and autonomous agents to investigate message intent and identity. AegisAI builds email security that uses language models and autonomous agents to investigate message intent and identity. | $36M | Series A | Cybersecurity | United States | Investors | |
| K K25.aiCompany profile Develops a livestreaming platform with interactive prediction markets for sports and entertainment. Develops a livestreaming platform with interactive prediction markets for sports and entertainment. | Undisclosed | Series A | Fintech | Singapore | Investors | |
| P PaperCompany profile Design platform for the agentic era, enabling designers and engineers to collaborate through a shared language. Design platform for the agentic era, enabling designers and engineers to collaborate through a shared language. | $34M | Series A | AI | United States | Investors | |
| TA Tikva AllocellCompany profile Developing engineered, allogeneic (donor-derived) cell therapies for adult and pediatric patients with solid tumors Developing engineered, allogeneic (donor-derived) cell therapies for adult and pediatric patients with solid tumors | $8M | Series A | Biotech | Singapore | Investors | |
| TB Transcripta BioCompany profile AI-powered drug discovery company developing treatments for neurological and neuromuscular diseases AI-powered drug discovery company developing treatments for neurological and neuromuscular diseases | $24M | Series A | Biotech | United States | Investors | |
| A ArrakisCompany profile AI software company helping industrial organisations deploy AI agents into mission-critical operational workflows AI software company helping industrial organisations deploy AI agents into mission-critical operational workflows | $30M | Series A | Industrial tech | United Kingdom | Investors | |
| NB N-Zyme BiomedicalCompany profile Developing first-in-class therapies targeting pepsin for reflux disease Developing first-in-class therapies targeting pepsin for reflux disease | $4.6M | Series A | Biotech | United States | Investors Undisclosed |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Clueso, Santé, Flai
52rounds0led - 2Andreessen Horowitz (a16z)
Eka Robotics, TypeSafe AI, Sharp Performance
29rounds9led - 3General Catalyst
Baba, Melius, Disha (formerly Curelink)
24rounds1led - 4Lightspeed
Warp Sciences, Zenzap, Avarra
21rounds4led - 5Alumni Ventures
Chariot Claims, RegCell, Inc., Lightfield
21rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.